Literature DB >> 16413968

Fluoxetine increases the nitric oxide production via nuclear factor kappa B-mediated pathway in BV2 murine microglial cells.

Eunyoung Ha1, Kyung Hee Jung, Bong-Keun Choe, Jae-Hoon Bae, Dong-Hoon Shin, Sung-Vin Yim, Hyung Hwan Baik.   

Abstract

A body of recent evidence implicates that antidepressants affect the inflammatory response and immune system. The present study is focused on the effects of the most widely used antidepressant agent, fluoxetine on the production of nitric oxide (NO) in BV2 microglial cells. In this study, we observed interesting result that NO production was increased by fluoxetine. The mRNA level of nitric oxide synthase (iNos, Nos2) by RT-PCR was also stimulated by fluoxetine. We next conducted electophoretic mobility shift assay (EMSA) to determine the DNA binding activity of nuclear factor kappa B (Nfkappab), an important upstream modulator for Nos2 expression, to find that fluoxetine increased DNA binding activity of Nfkappab. By Western blot analysis, phosphorylation levels of p38 mitogen-activated protein kinase (p38 Mapk, Mapk14) and extracellular signal-related kinase (Erk)1/2 Mapk, upstream signaling mediators of Nfkappab were found to be increased by fluoxetine. In addition, the mRNA expressions of other proinflammatory cytokines, interleukin 6 (Il6) and tumor necrosis factor alpha (Tnfalpha) were examined. The expressions of both Il6 and Tnfalpha by fluoxetine treatment were similar to those of Nos2 and Nfkappab. Taken together, our results show that fluoxetine stimulates NO production via Nfkappab-mediated pathway in BV2 cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16413968     DOI: 10.1016/j.neulet.2005.12.022

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  8 in total

1.  Fluoxetine inhibits inflammatory response and bone loss in a rat model of ligature-induced periodontitis.

Authors:  Luciana S Branco-de-Almeida; Gilson C Franco; Myrella L Castro; Juliana G Dos Santos; Ana Lia Anbinder; Sheila C Cortelli; Mikihito Kajiya; Toshihisa Kawai; Pedro L Rosalen
Journal:  J Periodontol       Date:  2011-10-03       Impact factor: 6.993

2.  Imipramine attenuates neuroinflammatory signaling and reverses stress-induced social avoidance.

Authors:  Karol Ramirez; Daniel T Shea; Daniel B McKim; Brenda F Reader; John F Sheridan
Journal:  Brain Behav Immun       Date:  2015-02-18       Impact factor: 7.217

3.  Possible involvement of NO-sGC-cGMP signaling in the antidepressant like effect of pyridoxine in mice.

Authors:  Sushma Maratha; Vijay Sharma; Vaibhav Walia
Journal:  Metab Brain Dis       Date:  2021-11-05       Impact factor: 3.584

4.  Fluoxetine Decreases Phagocytic Function via REV-ERBα in Microglia.

Authors:  Da-Yoon Jang; Bohyun Yang; Min-Jung You; Chan Rim; Hui-Ju Kim; Soyoung Sung; Min-Soo Kwon
Journal:  Neurochem Res       Date:  2022-09-01       Impact factor: 4.414

Review 5.  Repurposing psychiatric medicines to target activated microglia in anxious mild cognitive impairment and early Parkinson's disease.

Authors:  Edward C Lauterbach
Journal:  Am J Neurodegener Dis       Date:  2016-03-01

6.  Neurogenesis and increase in differentiated neural cell survival via phosphorylation of Akt1 after fluoxetine treatment of stem cells.

Authors:  Anahita Rahmani; Danial Kheradmand; Peyman Keyhanvar; Alireza Shoae-Hassani; Amir Darbandi-Azar
Journal:  Biomed Res Int       Date:  2013-08-18       Impact factor: 3.411

7.  The effect of different antidepressant drugs on oxidative stress after lipopolysaccharide administration in mice.

Authors:  Omar M E Abdel-Salam; Safaa M Youssef Morsy; Amany A Sleem
Journal:  EXCLI J       Date:  2011-12-08       Impact factor: 4.068

8.  Antineuroinflammatory and Neuroprotective Effects of Gyejibokryeong-Hwan in Lipopolysaccharide-Stimulated BV2 Microglia.

Authors:  Bo-Kyung Park; Young Hwa Kim; Yu Ri Kim; Jeong June Choi; Changsop Yang; Ik-Soon Jang; Mi Young Lee
Journal:  Evid Based Complement Alternat Med       Date:  2019-04-01       Impact factor: 2.629

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.